Enanta Pharmaceuticals Inc Long-term Investment Intensity
Enanta Pharmaceuticals Inc long-term investment intensity. Enanta Pharmaceuticals Inc (ENTA) has a Long-term Investment Intensity of 7.4% as of June 2026. Long-term investments of $21.99 Million represent 7.4% of total assets of $296.87 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Enanta Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Enanta Pharmaceuticals Inc (2014–2022)
Long-term investment intensity of Enanta Pharmaceuticals Inc from 2014 to 2022. This chart shows how Enanta Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2014 to 2022. As of June 2026, the intensity stands at 7.4%, reflecting long-term investments of $21.99 Million against total assets of $296.87 Million USD.
Enanta Pharmaceuticals Inc Long-term Investment Intensity by Year (2014–2022)
Enanta Pharmaceuticals Inc long-term investment intensity by year from 2014 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Enanta Pharmaceuticals Inc from 2014 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Enanta Pharmaceuticals Inc asset portfolio.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 7.7% | $29.29 Million | $380.59 Million | ▼ -16.9 pp |
| 2021 | 24.6% | $108.42 Million | $440.86 Million | ▲ +17.9 pp |
| 2020 | 6.6% | $32.63 Million | $490.79 Million | ▼ -6.6 pp |
| 2019 | 13.3% | $65.01 Million | $489.83 Million | ▲ +9.3 pp |
| 2018 | 4.0% | $16.39 Million | $414.23 Million | ▼ -17.5 pp |
| 2017 | 21.4% | $70.04 Million | $326.64 Million | ▲ +10.0 pp |
| 2016 | 11.4% | $32.12 Million | $281.28 Million | ▼ -14.7 pp |
| 2015 | 26.1% | $64.24 Million | $246.01 Million | ▼ -0.3 pp |
| 2014 | 26.4% | $41.00 Million | $155.41 Million | — |